Research published in June’s Vet Record discusses the attitudes and perceptions of vet professionals towards ADR reporting.
A survey was designed by the research team and advertised widely through conventional and social media and at several conferences.
In total, 260 respondents completed the survey, including 210 veterinary surgeons, 49 veterinary nurses and one suitably qualified person. Respondents generally understood the need to report ADRs.
The main barrier to reporting was the suspected ADR being well known, and the most popular potential facilitator identified was the ability to report via the practice management system. Facilitation via education in the form of a pharmacovigilance themed continuing professional development event was particularly popular among veterinary nurses, who reported time as being less of a barrier to reporting than their veterinary surgeon counterparts.
Spontaneous reporting of suspected adverse drug reactions is the cornerstone of pharmacovigilance. Despite this, it is believed that there is significant under-reporting in the veterinary setting. Low reporting rates delay marketing authorisation holders and regulators taking mitigating action in the case of safety concerns.
The study’s findings suggest that technological interventions to facilitate reporting and empowerment of veterinary nurses to report through a tailored training event should be explored further.
We receive many calls involving adverse reactions to drugs and are on hand to assist with these cases.
